Advertisement
Advertisement
KZIA
Kazia Therapeutics Limited - ADR
14.44
USDSponsored
+1.03
+7.68%
May 08, 16:00 UTC -4
Closed
After-Market
14.62
+0.18
+1.21%
KZIA Earnings Reports
Positive Surprise Ratio
KZIA beat 2 of 6 last estimates.
33%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Kazia Therapeutics Limited - ADR earnings per share and revenue
On Mar 19, 2026, KZIA reported earnings of -0.80 USD per share (EPS) for Q2 26, missing the estimate of -0.33 USD, resulting in a -142.84% surprise. Revenue reached 253.00 thousand, compared to an expected 51.00 thousand, with a 396.08% difference. The market reacted with a -5.44% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Werewolf Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+3.68%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
FAQ
What were Kazia Therapeutics Limited - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Kazia Therapeutics Limited - ADR reported EPS of -$0.80, missing estimates by -142.84%, and revenue of $253.00K, 396.08% above expectations.
How did the market react to Kazia Therapeutics Limited - ADR's Q2 2026 earnings?
The stock price moved down -5.44%, changed from $7.91 before the earnings release to $7.48 the day after.
When is Kazia Therapeutics Limited - ADR expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Kazia Therapeutics Limited - ADR's next earnings report?
Based on --
analysts, Kazia Therapeutics Limited - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement